Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.032 EUR | -5.84% | +10.15% | -42.73% |
14/03 | Abionyx Pharma: to benefit from a 1ME grant from Bpifrance | CF |
11/03 | Abionyx: reduced net loss in 2023 | CF |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Equities
- ABNX Stock
- 609 Stock
- Revisions ABIONYX Pharma